News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
455,170 Results
Type
Article (29223)
Company Profile (168)
Press Release (425779)
Section
Business (139691)
Career Advice (1564)
Deals (24051)
Drug Delivery (79)
Drug Development (49620)
Employer Resources (156)
FDA (10020)
Job Trends (10683)
News (226047)
Policy (18671)
Tag
Academia (2049)
Alliances (33145)
Alzheimer's disease (883)
Approvals (10004)
Artificial intelligence (108)
Bankruptcy (171)
Best Places to Work (8695)
Biotechnology (112)
Breast cancer (132)
Cancer (918)
Cardiovascular disease (75)
Career advice (1358)
CAR-T (72)
Cell therapy (208)
Clinical research (39819)
Collaboration (364)
Compensation (167)
COVID-19 (1496)
C-suite (96)
Data (1036)
Diabetes (113)
Diagnostics (4263)
Earnings (53094)
Employer resources (137)
Events (72067)
Executive appointments (335)
FDA (10528)
Funding (334)
Gene therapy (148)
GLP-1 (417)
Government (2482)
Healthcare (12747)
Infectious disease (1560)
Inflammatory bowel disease (95)
Interviews (229)
IPO (11488)
Job creations (2350)
Job search strategy (1194)
Layoffs (239)
Legal (4218)
Lung cancer (123)
Lymphoma (73)
Manufacturing (140)
Medical device (8552)
Medtech (8557)
Mergers & acquisitions (12759)
Metabolic disorders (307)
Neuroscience (1122)
NextGen Class of 2024 (4572)
Non-profit (3689)
Northern California (1254)
Obesity (174)
Opinion (130)
People (44162)
Phase I (11685)
Phase II (17367)
Phase III (14276)
Pipeline (395)
Postmarket research (1567)
Preclinical (5008)
Radiopharmaceuticals (181)
Rare diseases (202)
Real estate (4205)
Regulatory (12896)
Research institute (1814)
Resumes & cover letters (213)
Southern California (1020)
Startups (2755)
United States (10831)
Vaccines (286)
Weight loss (111)
Date
Today (15)
Last 7 days (57)
Last 30 days (1491)
Last 365 days (25672)
2024 (25672)
2023 (29315)
2022 (37231)
2021 (40834)
2020 (38209)
2019 (32390)
2018 (24296)
2017 (22279)
2016 (21359)
2015 (25028)
2014 (19126)
2013 (15447)
2012 (16562)
2011 (17130)
2010 (16317)
Location
Africa (569)
Arizona (114)
Asia (24691)
Australia (4128)
California (2719)
Canada (1160)
China (181)
Colorado (109)
Connecticut (140)
Europe (58319)
Florida (392)
Georgia (101)
Illinois (245)
Indiana (207)
Japan (79)
Maryland (383)
Massachusetts (2122)
Michigan (128)
Minnesota (204)
New Jersey (863)
New York (815)
North Carolina (602)
Northern California (1254)
Ohio (110)
Pennsylvania (613)
South America (782)
Southern California (1020)
Texas (381)
Washington State (218)
455,170 Results for "anavex life sciences corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Anavex Life Sciences Announces Expansion of Leadership Team
Anavex Life Sciences Corp. announced the addition and appointment of new senior team members with a track record of successfully bringing drugs to market.
May 22, 2024
·
6 min read
Pharm Country
Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL) today announced that Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, will present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference being held June 27, 2024.
June 20, 2024
·
3 min read
Press Releases
Anavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business Update
December 23, 2024
·
8 min read
Press Releases
Anavex Life Sciences to Announce Fiscal 2024 Fourth Quarter Financial Results on Monday, December 23, 2024
December 16, 2024
·
3 min read
Press Releases
Anavex Life Sciences to Present at the 7th Annual Evercore ISI HealthCONx Conference 2024
December 2, 2024
·
3 min read
Pharm Country
Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
Anavex Life Sciences Corp. today announced that it will present at the 23rd Annual Needham Virtual Healthcare Conference.
March 25, 2024
·
3 min read
Press Releases
Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer’s Disease to EMA
November 26, 2024
·
5 min read
Business
Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024
Anavex Life Sciences Corp. announced that it will issue financial results for its fiscal quarter ended March 31, 2024, on Thursday, May 9, 2024.
May 2, 2024
·
3 min read
Pharm Country
Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ
Anavex Life Sciences Corp. announced that Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, will participate in a fireside chat at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ being held May 20th, 2024 at 10:00am ET at NASDAQ World Headquarters New York City.
May 14, 2024
·
3 min read
Drug Development
Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
Anavex Life Sciences Corp today announced that the first patient in its U.S. FDA cleared placebo-controlled Phase 2 clinical study of ANAVEX®3-71 for the treatment of schizophrenia has been screened ahead of schedule.
March 18, 2024
·
8 min read
1 of 45,517
Next
